Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Stoke Therapeutics, Inc. - Common Stock
(NQ:
STOK
)
29.03
-0.31 (-1.06%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Sep 11, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Stoke Therapeutics, Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
12 Health Care Stocks Moving In Monday's After-Market Session
↗
March 25, 2024
Via
Benzinga
Stoke Therapeutics Stock Rockets On Phase 1/2a Data: Here's Why
↗
March 25, 2024
Stoke Therapeutics reported its fourth-quarter financial results and announced Phase 1/2a end of study data after the bell Monday. The company reported quarterly losses of 60 cents per share which beat...
Via
Benzinga
Stoke Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results
March 25, 2024
From
Stoke Therapeutics, Inc.
Via
Business Wire
Stoke Therapeutics Announces Landmark New Data That Support the Potential for STK-001 to be the First Disease-Modifying Medicine for the Treatment of Patients with Dravet Syndrome
March 25, 2024
From
Stoke Therapeutics, Inc.
Via
Business Wire
The Latest Analyst Ratings for Stoke Therapeutics
↗
July 31, 2023
Via
Benzinga
7 Biotech Penny Stocks on the Verge of Clinical Trial Victory
↗
February 25, 2024
Biotech penny stocks represent one heckuva risk. However, if the stars align, you could be talking some serious money.
Via
InvestorPlace
Stoke Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
January 17, 2024
From
Stoke Therapeutics, Inc.
Via
Business Wire
Stoke Therapeutics Highlights Strategic Priorities and Anticipated Milestones for 2024
January 08, 2024
From
Stoke Therapeutics, Inc.
Via
Business Wire
Stoke Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference
January 04, 2024
From
Stoke Therapeutics, Inc.
Via
Business Wire
Stoke Therapeutics Presents Data From Multiple Studies of Children and Adolescents With Dravet Syndrome at the American Epilepsy Society (AES) 2023 Annual Meeting
December 01, 2023
From
Stoke Therapeutics, Inc.
Via
Business Wire
Stoke Therapeutics to Present Data from the Company’s Dravet Syndrome Clinical Program at the American Epilepsy Society 2023 Annual Meeting
November 21, 2023
From
Stoke Therapeutics, Inc.
Via
Business Wire
Stoke Therapeutics Reports Third Quarter Financial Results and Provides Business Updates
November 07, 2023
From
Stoke Therapeutics, Inc.
Via
Business Wire
Stoke Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
October 17, 2023
From
Stoke Therapeutics, Inc.
Via
Business Wire
Stocks That Hit 52-Week Lows On Thursday
↗
September 21, 2023
During the session on Thursday, 461 stocks hit new 52-week lows.
Via
Benzinga
Stocks That Hit 52-Week Lows On Tuesday
↗
September 26, 2023
On Tuesday, 386 stocks made new 52-week lows.
Via
Benzinga
Stoke Therapeutics to Participate in the 2023 Cantor Global Healthcare Conference
September 21, 2023
From
Stoke Therapeutics, Inc.
Via
Business Wire
Stoke Therapeutics Appoints Ian Smith to its Board of Directors
September 20, 2023
From
Stoke Therapeutics, Inc.
Via
Business Wire
Stoke Therapeutics Presents Data Related to the Ongoing Clinical Development of STK-001 for the Treatment of Dravet Syndrome at the 35th International Epilepsy Congress
September 05, 2023
From
Stoke Therapeutics, Inc.
Via
Business Wire
This Under-the-Radar Growth Stock Could Soar by 277%, According to Wall Street
↗
August 16, 2023
This small-cap biotech might be a hidden gem.
Via
The Motley Fool
Stoke Therapeutics Reports Second Quarter Financial Results and Provides Business Updates
August 07, 2023
From
Stoke Therapeutics, Inc.
Via
Business Wire
Stoke Therapeutics to Present at the Canaccord Genuity 43rd Annual Growth Conference
August 02, 2023
From
Stoke Therapeutics, Inc.
Via
Business Wire
Stocks That Hit 52-Week Lows On Thursday
↗
July 27, 2023
During Thursday, 56 stocks hit new 52-week lows.
Via
Benzinga
Stocks That Hit 52-Week Lows On Wednesday
↗
July 26, 2023
Wednesday saw 59 companies set new 52-week lows.
Via
Benzinga
Why Shares of Stoke Therapeutics Plummeted Tuesday
↗
July 25, 2023
The company's shares fell after it released early trial results on its lead therapy.
Via
The Motley Fool
Crude Oil Up 1%; Verizon Earnings Beat Views
↗
July 25, 2023
U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite gaining more than 100 points on Tuesday. The Dow traded up 0.28% to 35,510.96 while the NASDAQ rose 0.91% to 14,187.05....
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
↗
July 25, 2023
Via
Benzinga
Why Alaska Air Group Shares Are Trading Lower By 9%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
↗
July 25, 2023
Gainers Aurora Acquisition Corp. (NASDAQ: AURC) shares jumped 192% to $30.54.
Via
Benzinga
Why Stoke Therapeutics Is Trading Lower Today?
↗
July 25, 2023
Stoke Therapeutics Inc (NASDAQ: STOK) shares are trading lower after the company released new safety & efficacy data from STK-001 in the Phase 1/2a Studies (MONARCH & ADMIRAL) and the SWALLOWTAIL...
Via
Benzinga
Stocks That Hit 52-Week Lows On Tuesday
↗
July 25, 2023
On Tuesday, 56 companies set new 52-week lows.
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
↗
July 25, 2023
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
